AGN News 168.15 04/26/2014 00:16:26 Allergan Inc (AGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Inc (AGN) 168.15 $AGN

IBD 50: Valeant Taking The Buyout Route To Growth
at Investor's Business Daily - Fri Apr 25, 5:42PM CDT
Valeant Pharmaceuticals (VRX) is using buyouts to boost its business. The diversified Canadian drugmaker has made a boatload of buyouts, including a couple of big ones. In August, Valeant wrapped up its $8.7 billion acquisition of eye-care giant...

Wachtell Sees 'Threat' in Ackman's Allergan Bid
at The Street - Fri Apr 25, 3:48PM CDT
Activist investor critic Wachtell Lipton said hedge fund Pershing Square Capital Management's role in Valeant Pharmaceuticals $45 billion bid for Allergan was a new threat to Corporate America.

AbbVie Beats on Q1 Earnings, Humira Soars - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 3:45PM CDT
AbbVie (ABBV) surpassed expectations in the first quarter on the back of strong Humira sales.

Novartis Misses on Earnings & Revs in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 11:00AM CDT
Novartis (NVS) reported first quarter 2014 earnings per share of $1.21. Core earnings per share came in at $1.31, up 6% from the year-ago period but missed the Zacks Consensus Estimate of $1.33.

Prestige Brands Acquires Insight for $750M
at The Street - Fri Apr 25, 10:52AM CDT
Deal for feminine care product maker caps an active week for pharmaceutical mergers.

AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 9:30AM CDT
AstraZeneca's first-quarter 2014 core earnings of $1.17 per American Depositary Share missed the Zacks Consensus Estimate of $1.20.

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
PR Newswire - Fri Apr 25, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan, Inc. (NYSE: AGN), Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Actavis plc (NYSE: ACT) and Express Scripts Holding Company (NASDAQ: ESRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1586-100free.

Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 5:33PM CDT
Glaxo (GSK) and partner Theravance (THRX) announced the initiation of a phase III study on Relvar Ellipta.

Inside Valeant Pharmaceuticals' Bid for Allergan
Brendan Mathews, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Earlier this week, Valeant Pharmaceutical made a public offer to buy rival Allergan . Let's review the major questions this huge potential deal raises, to see whether it's a smart move – and whether or not it'll actually happen. What is...

Valeant Eyes Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 4:40PM CDT
Shares of Allergan (AGN) gained 15.2% after Valeant Pharmaceuticals International, Inc. (VRX) and Pershing Square Capital Management, L.P made a formal proposal to acquire the former.

Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available
CNW Group - Thu Apr 24, 2:16PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square" today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J. Michael Pearson and Pershing Square Chief Executive Officer, William A. Ackman, outlining Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The webcast and presentations can be accessed by visiting www.vpsevent.com/webcast.

Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 12:50PM CDT
Eli Lilly's (LLY) first quarter revenues were hurt by the genericization of two major products - Cymbalta and Evista.

Zimmer Bolts on Biomet for $13.4B
at The Street - Thu Apr 24, 10:47AM CDT
Sponsors Blackstone, TPG, KKR and Goldman forgo planned IPO in sale of orthopedic device maker.

Botox at the Center of Recent Healthcare M&A Flurry
at The Street - Thu Apr 24, 10:07AM CDT
How wrinkle reduction is at the crux of the recent M&A frenzy....

Jim Cramer's 'Mad Money' Recap: The Market's New Reality
at The Street - Wed Apr 23, 7:20PM CDT
Investors are focusing on the positive instead of the negative, Cramer says.

Encouraging Results from Pfizer's Xeljanz - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 5:20PM CDT
Pfizer Inc. (PFE) announced encouraging top-line results from two pivotal phase III studies from the OPT Program on Xeljanz.

Fitch Places Allergan's Ratings on Negative Watch
Business Wire - Wed Apr 23, 2:32PM CDT
Fitch Ratings has placed the ratings for Allergan Inc. (Allergan), including the 'A+' Issuer Default Rating (IDR), on Rating Watch Negative. The rating action stems from Valeant Pharmaceuticals International Inc.'s (Valeant) unsolicited offer to acquire Allergan for approximately $45.6 billion. The rating action applies to $2.1 billion of outstanding Allergan debt. A complete list of ratings is provided at the end of this release.

Can Allergan Find an Alternative To Valeant?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 23, 1:30PM CDT
No one will accuse Valeant CEO Mike Pearson of lacking boldness. He has laid out a strategy for turning Valeant into one of the largest pharmaceutical/med-tech companies in the world and has proven more than willing to turn to bold...

Stock Market News for April 23, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 9:06AM CDT
Benchmarks ended higher on Tuesday boosted by better-than-expected corporate results
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 61

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 236

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 114

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Pinot's Palette Expands with New La Quinta Studio

Updated Category News Views 79

Canvas and Cabernet in Coachella Valley Grab your brushes and wine glasses; Pinot's Palette is branching out to La Quinta. As of November 27, locals and visitors alike can find their artistic flair at 47120 Dune Palms Road. This move isn’t just another business expansion—it's about blending community spirit with creativity, backed by the experienced entrepreneurs...

Continue Reading
Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 102

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 206

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 39

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 94

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocean Power Technologies Enhances Market Reach with New Partnership

Updated Category News Views 124

Expanding Horizons in Latin America Ocean Power Technologies, Inc. (NYSE American: OPTT), a pioneer in low-carbon marine power solutions, has taken a significant step in expanding its operational footprint by signing a reseller agreement in Latin America. This significant partnership primarily targets the offshore and maritime sectors in Mexico. A New Partnership for...

Continue Reading
Aktsiaselts Infortar's Strategic Move in the Polish Energy Sector

Updated Category News Views 121

Aktsiaselts Infortar Expands Into Poland's Energy Market Aktsiaselts Infortar, through its wholly owned subsidiary AS Eesti Gaas, has taken a significant step in its growth strategy by acquiring 100% of EWE Polska sp. z o.o., an important player in the Polish energy sector. This strategic acquisition enables Infortar to broaden its operational footprint beyond the...

Continue Reading
Exciting Insights Await at Can-Fite's Live Investor Webinar

Updated Category News Views 151

Join Can-Fite BioPharma's Informative Live Investor Webinar Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is thrilled to announce an exclusive live investor webinar aimed at sharing vital insights into their innovative drug pipeline. This engaging session will take place on a Tuesday afternoon, providing an excellent opportunity for investors and stakeholders...

Continue Reading
Ajinomoto Co. Partners with LabCentral to Boost Biotech Innovation

Updated Category News Views 365

Ajinomoto Co., Inc. Enhances Biotech Innovation Ajinomoto Co., Inc., a prominent player in biotechnology and food innovation, recently unveiled its full-scale support for LabCentral, a distinguished platform for startups in the biosciences sector. This initiative reaffirms the Ajinomoto Group's dedication to innovation and collaborative growth within an ever-evolving...

Continue Reading
ATI Physical Therapy's Strategic Shift to Private Ownership

Updated Category News Views 610

ATI Physical Therapy Shifts to Private Ownership ATI Physical Therapy, Inc. (OTC: ATIP), known for its outstanding outpatient physical therapy and rehabilitation services, has made a significant transition. In a recent announcement, the company disclosed its evolution from public to private ownership, led by a consortium of existing shareholders including Knighthead...

Continue Reading